|
⚲
|
| Keyboard |
| Logos Global Management LP
✚
|
|
|---|---|
| CRD # | 305162 |
| SEC # | 801-117248 |
| CIK # | 0001792126 |
| AUM | 2,252.5 M (2026-04-22) |
| Employees | 9 (56% Investors, 0% Brokers) |
| Phone | 415-801-4660 |
| Address | 1 Letterman Drive San Francisco, CA 94129 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Revolution Medicines Inc | 0.2 | ||
| Erasca Inc | 0.2 | ||
| IDEAYA Biosciences Inc | 0.1 | ||
| Praxis Precision Medicines Inc | 0.1 | ||
| Abivax Sa | 0.1 | ||
| BCTG Acquisition Corp | 0.1 | ||
| Cytokinetics Inc | 0.1 | ||
| Olema Pharmaceuticals Inc | 0.0 | ||
| United Therapeutics Corp | 0.0 | ||
| Immunocore Holdings PLC | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Logos Opportunities Fund V LP | [2026-03-31] | 250.2 M | |
| Filed 2025-02-03 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | Logos Opportunities Fund IV LP | [2024-03-29] | 284.0 M | 361.9 M |
| Filed 2024-07-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | Logos Opportunities Fund III LP | [2022-03-31] | 208.1 M | 68.0 M |
| Filed 2021-05-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | Logos SPV 1 LP | [2022-03-31] | ||
| Filed 2021-01-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Logos Opportunities Fund II LP | [2021-03-31] | 44.0 M | 42.1 M |
| Filed 2020-02-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| VC | Logos Opportunities Fund I LP | [2019-12-23] | 44.0 M | |
| Filed 2020-02-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Logos Global Master Fund LP | [2019-07-26] | 266.1 M | 1,530.3 M |
| Filed 2025-08-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 2.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 2.3 |
| By Discretionary | ||
| Discretionary | 8 | 2.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 2.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.8 | |
| United States Persons | 1.5 | |
| Total | 8 | 2.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ronan Guilfoyle | Director | 358 | 108 | |
| Wade Kenny | Director | 86 | 31 | |
| Virginia Yee | Executive Officer | 7 | 3 | |
| Arsani William | Director, Executive Officer | 9 | 2 | |
| Graham Walmsley | Executive Officer | 9 | 2 | |
| Edward Zhong | Executive Officer | 6 | 2 | |
| Yanni Souroutzidis | Executive Officer | 4 | 2 | |
| Edward Callaway | Executive Officer | 4 | 2 | |
| Derek Gould | Executive Officer | 3 | 2 | |
| Logos GP LLC | Executive Officer | 3 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001792126] | |
| 3 | [0001792126] | |
| 4 | [0001792126] | |
| SC 13D | [0001792126] | |
| SC 13G | [0001792126] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 5493000DTXD20QIYQ102 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Verve Therapeutics Inc | |
| Logos Global Management LP | |
| Tokai Pharmaceuticals Inc | |
| Dyne Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Buy | 370,000 | $19.00 | 7,030,000 |
|
Verve Therapeutics Inc VERV
Series B Preferred Stock · derivative
|
2021-06-21 | Conversion | 4,104,416 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2021-06-21 | Conversion | 443,265 | ||
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Sell | 12,942 | $26.64 | 344,775 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 12,942 | $25.88 | 334,939 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Sell | 27 | $27.02 | 730 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 15,000 | $26.17 | 392,550 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 5,000 | $24.03 | 120,150 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 31,000 | $24.53 | 760,430 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 4,000 | $25.97 | 103,880 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 15,000 | $26.48 | 397,200 |
|
Tokai Pharmaceuticals Inc NVUS
Common Stock
|
2020-10-30 | Buy | 9,098 | $25.55 | 232,454 |
|
Dyne Therapeutics Inc DYN
Series B Preferred Stock · derivative
|
2020-09-21 | Conversion | 2,668,089 | $0.00 | |
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Conversion | 804,392 | ||
|
Dyne Therapeutics Inc DYN
Common Stock
|
2020-09-21 | Buy | 700,000 | $19.00 | 13,300,000 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Jana Partners Management LP
✚
|
NY | 2,286.4 M |
|
Clocktower Group LP
✚
|
CA | 2,283.0 M |
|
Asset Value Investors Limited
✚
|
2,280.8 M | |
|
M Square Investimentos LTDA
✚
|
2,251.5 M | |
|
Browning West LP
✚
|
CA | 2,243.7 M |
|
Troluce Capital Advisors LLC
✚
|
PR | 2,242.4 M |
|
Entropy Technologies LP
✚
|
NY | 2,238.1 M |
|
Passaic Partners LLC
✚
|
NJ | 2,237.5 M |
|
Absolute Investment Advisers LLC
✚
|
FL | 2,233.9 M |
|
APS Asset Management PTE Ltd
✚
|
2,225.9 M |